CFD
SUPN icon

Creative Financial Designs’s Supernus Pharmaceuticals SUPN Stock Holding History

Creative Financial Designs’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-297
Closed -$8K – 1428
2021
Q3 		$8K Hold
297
– – ﹤0.01% 1070
2021
Q2 		$9K Hold
297
– – ﹤0.01% 1052
2021
Q1 		$8K Hold
297
– – ﹤0.01% 978
2020
Q4 		$7K Hold
297
– – ﹤0.01% 927
2020
Q3 		$6K Hold
297
– – ﹤0.01% 903
2020
Q2 		$7K Buy
+297
New +$6.56K ﹤0.01% 821

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Creative Financial Designs's SUPN Position: Q4 2021 in Review

Creative Financial Designs sold out of Supernus Pharmaceuticals (SUPN) in Q4 2021, closing a stake of 297 shares — an estimated $8K sold.

Creative Financial Designs first reported a position in SUPN in Q2 2020 and held it in 6 quarters. The position peaked at $9K in Q2 2021. 235 funds tracked by Wall St. Rank hold SUPN as of Q4 2021.

  • Creative Financial Designs reported no remaining Supernus Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Creative Financial Designs sold 297 Supernus Pharmaceuticals shares in Q4 2021, an estimated $8K.
  • Creative Financial Designs first reported a position in Supernus Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Creative Financial Designs's Supernus Pharmaceuticals position peaked at $9K in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2021.

Based on Creative Financial Designs's 13F filing for Q4 2021, filed 26 Jan 2022.